EUVIMEDEUVIMED entdecken
Crossref

The current landscape of clinical exome and genome reanalysis in the U.S.

Michelle Frees iD, Jennefer N Carter iD, Matthew T Wheeler iD, Chloe Reuter iD

Journal of Genetic Counseling · 2025-04 · 34 (2)

DOI: 10.1002/jgc4.1968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Genetic Counseling, online erschienen am 16.09.2024. Verfasst von Michelle Frees und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Exome, Genetic Testing, Genome, Human, Exome Sequencing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Common Fund, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The majority of patients undergoing exome or genome sequencing receive a nondiagnostic result. Periodic reanalysis is known to increase diagnostic yield from exome sequencing, yet laboratory reanalysis practices are obscure. We sought to define the landscape of exome and genome reanalysis across clinical laboratories. Genetic testing registries were queried to identify eligible clinical genetic laboratories offering exome and/or genome sequencing in the United States. A survey administered to lab representatives investigated reanalysis offerings, policies, perceived uptake, bioinformatic steps, and billing options. The analysis consisted of descriptive statistics. Survey data were collected from 30 of 32 eligible laboratories (93%), comprising 28 exome products and 13 genome products. Reanalysis was widely available for both exomes ( n = 27/28, 96%) and genomes ( n = 12/13, 92%). Most participating laboratories required ordering providers to initiate reanalysis ( n = 24/28, 86%). Most respondents estimated providers initiated reanalysis in less than 10% of all exomes ( n = 12/22) or genomes ( n = 6/9) sequenced. The approach to reanalysis varied greatly by laboratory. Laboratory approaches to exome and genome reanalysis are highly variable and typically require provider initiation. This could contribute to low reanalysis uptake and increased administrative burden on providers. Further work should emphasize development of clinical exome and genome reanalysis standards.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExomeGenetic TestingGenome, HumanExome SequencingHumansUnited States

Stichwörter der Autor:innen

exome reanalysisexome sequencinggenetic testinggenome reanalysisgenome sequencing

Autor:innen und Institutionen

  • Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.
  • Division of Genomic Medicine, UC Davis Medical Center, Sacramento, California, USA.
  • Center for Undiagnosed Diseases, Stanford University, Stanford, California, USA.
  • Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Center for Inherited Cardiovascular Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Michelle Frees, Jennefer N Carter, Matthew T Wheeler, Chloe Reuter

Förderung

  • Common Fund
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Frees, M., Carter, J. N., Wheeler, M. T., & Reuter, C. (2025). The current landscape of clinical exome and genome reanalysis in the U.S. Journal of Genetic Counseling, 34(2). https://doi.org/10.1002/jgc4.1968

Vancouver

Frees M, Carter JN, Wheeler MT, Reuter C. The current landscape of clinical exome and genome reanalysis in the U.S. Journal of Genetic Counseling. 2025;34(2). doi:10.1002/jgc4.1968

BibTeX
@article{Frees2025,
  author = {Frees, Michelle and Carter, Jennefer N and Wheeler, Matthew T and Reuter, Chloe},
  title = {The current landscape of clinical exome and genome reanalysis in the U.S},
  journal = {Journal of Genetic Counseling},
  year = {2025},
  volume = {34},
  number = {2},
  doi = {10.1002/jgc4.1968}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche